Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes.

[1]  P. Duerksen-Hughes,et al.  The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes. , 2007, Cancer research.

[2]  R. Skotheim,et al.  Alternative splicing in cancer: noise, functional, or systematic? , 2007, The international journal of biochemistry & cell biology.

[3]  D. Goldstein,et al.  Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease , 2007, Genome Biology.

[4]  P. Fisher,et al.  mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine. , 2006, Pharmacology & therapeutics.

[5]  P. Duerksen-Hughes,et al.  The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose , 2005, Cell Death and Differentiation.

[6]  S. Brenner,et al.  Global analysis of positive and negative pre-mRNA splicing regulators in Drosophila. , 2005, Genes & development.

[7]  F. Clark,et al.  Understanding alternative splicing: towards a cellular code , 2005, Nature Reviews Molecular Cell Biology.

[8]  Gordon K. Smyth,et al.  limmaGUI: A graphical user interface for linear modeling of microarray data , 2004, Bioinform..

[9]  P. Duerksen-Hughes,et al.  The Human Papillomavirus 16 E6 Protein Binds to Fas-associated Death Domain and Protects Cells from Fas-triggered Apoptosis* , 2004, Journal of Biological Chemistry.

[10]  A. Thorburn,et al.  Death receptor-induced cell killing. , 2004, Cellular signalling.

[11]  J. Castle,et al.  Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.

[12]  M. Zöller,et al.  CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation , 2003, Journal of Molecular Histology.

[13]  P. Duerksen-Hughes,et al.  Inorganic and dimethylated arsenic species induce cellular p53. , 2003, Chemical research in toxicology.

[14]  Stefan Stamm,et al.  Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. , 2002, Human molecular genetics.

[15]  Helen Song,et al.  The Human Papillomavirus 16 E6 Protein Binds to Tumor Necrosis Factor (TNF) R1 and Protects Cells from TNF-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[16]  E. Nishida,et al.  Identification and Characterization of a Novel MAP Kinase Kinase Kinase, MLTK* , 2001, The Journal of Biological Chemistry.

[17]  D. Scott,et al.  Death the Fas way: regulation and pathophysiology of CD95 and its ligand. , 2000, Pharmacology & therapeutics.

[18]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[19]  J. Lis,et al.  Pre-mRNA Splicing by the EssentialDrosophila Protein B52: Tissue and Target Specificity , 2000, Molecular and Cellular Biology.

[20]  I. Herr,et al.  Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells , 1996, Nature Medicine.

[21]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[22]  Stefan Stamm,et al.  Pre-mRNA missplicing as a cause of human disease. , 2006, Progress in molecular and subcellular biology.